title: Maintenance treatment in metastatic colorectal cancer.
authors.affiliation: Department of Medical Oncology, Institut Hospitalier Franco-Britannique, 92300 Levallois-Perret, France.
authors.forename: Benoist
authors.initials: B
authors.lastname: Chibaudel
authors.affiliation: Methodology and Quality of Life Unit, Besançon, France.
authors.forename: Franck
authors.initials: F
authors.lastname: Bonnetain
authors.affiliation: Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Paris-Est Créteil University, Créteil, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Tournigand
authors.affiliation: Department of Medical Oncology, Institut Hospitalier Franco-Britannique, 92300 Levallois-Perret, France. Electronic address: aimerydegramont@gmail.com.
authors.forename: Aimery
authors.initials: A
authors.lastname: de Gramont
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D000069287:Capecitabine / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D060046:Maintenance Chemotherapy; D008297:Male; D009944:Organoplatinum Compounds / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D009944:Organoplatinum Compounds; D000068258:Bevacizumab; D000069287:Capecitabine; D002955:Leucovorin; D005472:Fluorouracil